Clinical Study

Dynamics of B-Cell Populations in CSF and Blood in Patients Treated with a Combination of Rituximab and Mitoxantrone

Figure 4

Dynamic of Gd-enhanced lesions after therapy with rituximab with mitoxantrone and intravenous methylprednisolone during observation period. Along the period of observation after combined therapy, there were neither Gd-enhancing MRI lesions nor new T2 lesions in any of the study patients.
748127.fig.004